Contributions of the Combined Effects of Topoisomerase Mutations toward Fluoroquinolone Resistance in Escherichia coli

par Morgan-Linnell, Sonia K., Zechiedrich, Lynn
Publié 2007

Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates

par Morgan-Linnell, Sonia K., Becnel Boyd, Lauren, Steffen, David, Zechiedrich, Lynn
Publié 2009

Assessing Sensitivity to Antibacterial Topoisomerase II Inhibitors

par Morgan-Linnell, Sonia K., Hiasa, Hiroshi, Zechiedrich, Lynn, Nitiss, John L.
Publié 2007

Expression of Multidrug Efflux Pump Genes acrAB-tolC, mdfA, and norE in Escherichia coli Clinical Isolates as a Function of Fluoroquinolone and Multidrug Resistance

par Swick, Michelle C., Morgan-Linnell, Sonia K., Carlson, Kimberly M., Zechiedrich, Lynn
Publié 2011

Relationships among Ciprofloxacin, Gatifloxacin, Levofloxacin, and Norfloxacin MICs for Fluoroquinolone-Resistant Escherichia coli Clinical Isolates

par Becnel Boyd, Lauren, Maynard, Merry J., Morgan-Linnell, Sonia K., Horton, Lori Banks, Sucgang, Richard, Hamill, Richard J., Jimenez, Javier Rojo, Versalovic, James, Steffen, David, Zechiedrich, Lynn
Publié 2009

Dual EGFR inhibition in combination with anti-VEGF treatment: A phase I clinical trial in non-small cell lung cancer

par Falchook, Gerald S., Naing, Aung, Hong, David S., Zinner, Ralph, Fu, Siqing, Piha-Paul, Sarina A., Tsimberidou, Apostolia M., Morgan-Linnell, Sonia K., Jiang, Yunfang, Bastida, Christel, Wheler, Jennifer J., Kurzrock, Razelle
Publié 2013